APCCC 2024: Testosterone Recovery After Stopping ADT – Who Is at Risk for Long-Term Non-Recovery?
Were you unable to attend APCCC 2024? Get all of the groundbreaking research, new guidelines, and the latest advances in urologic medicine you missed.
Were you unable to attend APCCC 2024? Get all of the groundbreaking research, new guidelines, and the latest advances in urologic medicine you missed.
Zach Klaassen discusses the evolving landscape of non-metastatic castration-resistant prostate cancer (nmCRPC) with Neal Shore. They delve into the significant impact of PSMA PET scans…
A newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune patient samples from samples of patients previously infected with the related dengue virus.…
A multi-pronged approach is needed to stop the next global health threat, and doctors play a vital role.
Boris Hadaschik discusses the ongoing PRIMORDIUM phase three trial. The study explores the efficacy of adding six months of apalutamide to ADT in men with…
CDC’s mental health website provides basic public health information about mental health including surveillance, disorders, myths and facts, and prevention.
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alicia…
Learn the causes, risks, and what to do if you suspect sepsis.
Harris Macdonnell took his own life after fearing he would be sent back to the Huntlyburn ward.
Takeda Pharmaceutical has secured an option on an Alzheimer’s disease immunotherapy from AC Immune that is on track to report its first Phase 2 data…
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term illness. It causes severe fatigue and many other symptoms. Learn about managing them.